Exclusive: Bain scoops up $3B for fourth life sciences fund after handful of M&A deals
Bain Capital Life Sciences has reeled in about $3 billion for its fourth fund, Endpoints News has learned.
The Boston-based firm has been on a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
